Literature DB >> 10392615

Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice.

R Dalseg1, E Wedege, J Holst, I L Haugen, E A Høiby, B Haneberg.   

Abstract

Outer membrane vesicles (OMVs) from group B meningococci induced both serum and mucosal antibodies when given as a nasal and rectal vaccine to mice. Cholera toxin (CT) enhanced the antibody responses in serum both after nasal and rectal immunizations, and the mucosal responses after rectal immunizations only. Nasal immunizations, however, were most effective, with mucosal responses which were not dependent on the use of CT. The serum bactericidal activity was similarly not enhanced by CT, indicating that the positive effect of CT on the serum IgG level was not including bactericidal activity. A small nasal booster dose induced antibody responses in serum as far as eight months after intranasal and subcutaneous immunizations, and in saliva after intranasal immunizations. Nasal vaccines may thus be favorably combined with parenteral vaccines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392615     DOI: 10.1016/s0264-410x(99)00046-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.

Authors:  H Bakke; K Lie; I L Haugen; G E Korsvold; E A Høiby; L M Naess; J Holst; I S Aaberge; F Oftung; B Haneberg
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.

Authors:  B K Hvalbye; I S Aaberge; M Løvik; B Haneberg
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbits.

Authors:  David R Shoemaker; Nancy B Saunders; Brenda L Brandt; E Ellen Moran; Andrew D Laclair; Wendell D Zollinger
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.

Authors:  L Goetsch; A Gonzalez; H Plotnicky-Gilquin; J F Haeuw; J P Aubry; A Beck; J Y Bonnefoy; N Corvaïa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines.

Authors:  Libuse Janakova; Hilde Bakke; Inger Lise Haugen; Aud K H Berstad; E Arne Høiby; Ingeborg S Aaberge; Bjørn Haneberg
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

7.  Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis.

Authors:  Terry Guthrie; Simon Y C Wong; Bin Liang; Lisa Hyland; Sam Hou; E Arne Høiby; Svein Rune Andersen
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function.

Authors:  Hannah S W Lee; Ian C Boulton; Karen Reddin; Henry Wong; Denise Halliwell; Ofer Mandelboim; Andrew R Gorringe; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

9.  A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs).

Authors:  Sihan Wang; Jin Gao; Mo Li; Liguo Wang; Zhenjia Wang
Journal:  Biomaterials       Date:  2018-10-01       Impact factor: 12.479

10.  Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.

Authors:  Stefan Schild; Eric J Nelson; Anne L Bishop; Andrew Camilli
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.